CVS Health Corp (CVS)
68.14
+1.77 (2.67%)
NYSE · Last Trade: Jun 27th, 1:51 AM EDT
Detailed Quote
Previous Close | 66.37 |
---|---|
Open | 66.80 |
Bid | 67.60 |
Ask | 68.30 |
Day's Range | 66.72 - 68.54 |
52 Week Range | 43.56 - 72.51 |
Volume | 8,103,968 |
Market Cap | 89.92B |
PE Ratio (TTM) | 16.22 |
EPS (TTM) | 4.2 |
Dividend & Yield | 2.660 (3.90%) |
1 Month Average Volume | 7,439,536 |
Chart
About CVS Health Corp (CVS)
CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More
News & Press Releases
The case stems from a whistleblower lawsuit filed by a former Aetna actuary who alleged CVS Caremark manipulated drug pricing to inflate Medicare claims while underpaying pharmacies.
Via Stocktwits · June 26, 2025
Shares of CVS Health are trading higher Thursday afternoon. The stock is climbing after a GOP healthcare bill hit a roadblock in the Senate.
Via Benzinga · June 26, 2025
The provisions at risk include the plan to hold down Medicaid costs by cracking down on a state provider tax.
Via Stocktwits · June 26, 2025
Each stock in this article is trading near its 52-week high.
These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Via StockStory · June 26, 2025
Several major U.S. health insurers announce they will voluntarily speed up and simplify the prior authorization process.
Via Benzinga · June 23, 2025
Donald Trump Jr. has joined Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren's approach to healthcare pricing.
Via Benzinga · June 21, 2025
Via Benzinga · June 20, 2025
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
Via Benzinga · June 20, 2025
The research firm expects lower enrollment growth as UnitedHealth exits unprofitable plans and prioritizes margin discipline.
Via Stocktwits · June 19, 2025
The draft Senate bill introduces stricter work requirements and funding curbs for Medicaid, while shelving proposed Medicare cuts that could have impacted major insurers.
Via Stocktwits · June 16, 2025
Several major large-cap stocks, each with a market capitalization of over $30 billion, have recently announced notable increases to their quarterly dividends. These updates, aligned with recent shareholder meetings and strategic decisions, reflect efforts to enhance shareholder value and demonstrate financial strength.
Via MarketBeat · June 16, 2025
Via The Motley Fool · June 14, 2025
Synergy CHC Corp. (NASDAQ: SNYR), a fast-rising force in the consumer health and wellness space, has appointed Damian Marano as Vice President of Beverage in a strategic move aimed at catapulting the company’s FOCUSfactor Energy Drink into global markets. Marano, a seasoned executive with a decorated history at The Coca-Cola Company (NYSE: KO), brings a wealth of expertise that could unlock powerful international distribution opportunities for the brand.
Via AB Newswire · June 10, 2025

Humana is joining lawmakers in support of limiting Medicare Advantage payments tied to home visit diagnoses.
Via Benzinga · June 5, 2025

Synergy CHC Corp. (NASDAQ: SNYR), a provider of consumer health and lifestyle products, most notably “Focusfactor” , today announced a transformative $20 million financing agreement with ACP Agency, LLC , aimed at reducing legacy debt, boosting liquidity, and accelerating the company’s global growth strategy.
Via AB Newswire · June 4, 2025

Nearly 80% of S&P 500 firms beat Q1 earnings forecasts. Profit growth hit 13.3%, led by tech and health care, says FactSet.
Via Benzinga · June 3, 2025

Amazon Pharmacy introduces caregiver support and expands PillPack access for Medicare users, simplifying medication routines with secure tools and pre-sorted packets.
Via Benzinga · June 3, 2025

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · May 30, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.
However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Via StockStory · May 30, 2025

Synergy CHC Corp. (NASDAQ: SNYR) is a consumer healthcare and beauty company established in 2010, focuses on marketing and distributing a diverse portfolio of health, wellness, and lifestyle brands across the United States, Canada, and the United Kingdom. The company is anchored by a portfolio of dynamic consumer health and lifestyle brands designed for today's wellness-conscious market:
Via AB Newswire · May 29, 2025

Synergy CHC Corp. (NASDAQ: SNYR), a leading provider of consumer health and lifestyle products, today announced the appointment of Erik Shields as Vice President of Beverage, effective May 26, 2025. The strategic hire comes as the company accelerates its entry into the fast-growing functional beverage market with the expansion of its flagship brain health brand, FOCUSfactor .
Via AB Newswire · May 29, 2025

Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?
Via Investor's Business Daily · May 29, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Humana (NYSE:HUM) and the best and worst performers in the health insurance providers industry.
Via StockStory · May 28, 2025